Gastroesophageal Reflux Disease (GERD) Device Market Size, Share, By Device Type (Anti-Reflux Surgery Devices, Endoscopic Devices, Drug Delivery Devices Surgery, Monitoring Devices, and Others), By Application (Treatment, Diagnostics, and Monitoring), By End User (Hospitals, Ambulatory Surgery Centers, and Others), and By Region - Trends, Analysis and Forecast Till 2034

Gastroesophageal reflux disease (GERD) device market size was valued at USD 5.53 Billion in 2024 and is expected to reach USD 6.52 Billion by 2034, growing at a CAGR of 1.8%

Gastroesophageal Reflux Disease devices are medical instruments designed to cure chronic acid reflux by attacking the very roots of this disease. These instruments strengthen the lower esophageal sphincter- a muscular ring located at the bottom of the esophagus, which guards against the backward flow of stomach contents. In patients with GERD, this sphincter is either weak or defective and thus promotes frequent reflux episodes.

One of the most common devices for GERD is the LINX Reflux Management System. It is a small, flexible ring of magnetic titanium beads that is surgically placed around the LES. The magnetic attraction between the beads helps to keep the sphincter closed to prevent reflux yet still allows food and liquid to pass through when swallowing. Another device is the Stretta System, which uses radiofrequency energy to strengthen and thicken the LES and surrounding tissues. This is a non-surgical procedure executed endoscopically, aiming at improving LES barrier function. The EsophyX device is deployed using the Transoral Incisionless Fundoplication, or TIF, technique. Using minimal access, a valve is formed at the gastroesophageal junction by folding a part of the stomach around the lower esophagus and securing it. This dramatically improves the anti-reflux barrier without the need for external incisions. Another endoscopic device is the MUSE-or Medigus Ultrasonic Surgical Endostapler-system, which makes a similar fundoplication-like structure to obstruct reflux.

Electrical stimulation systems, like the EndoStim system, have been developed for those with more serious GERD who do not respond to other treatments. These devices strengthen the LES through low-energy electrical pulses, thus possibly enhancing its function over time. Neurostimulation approaches, though still relatively new, show some promise in managing refractory GERD. It's important to note that the effectiveness and suitability of these devices can vary depending on the individual patient's condition, anatomy, and specific symptoms. As with any medical intervention, using GERD devices should be carefully considered in consultation with a healthcare provider, considering potential benefits, risks, and alternative treatment options.

                             To Know More, Request Free Sample Report

Key Drivers of Target Market:

Rising Prevalence of GERD

• The increasing prevalence of the disease due to lifestyle factors such as obesity, unhealthy diet, and stress will create opportunities for new effective treatment options. It, therefore, encourages demand for GERD devices, presenting alternatives to traditional management.

Technological Advancements

• This includes the technological advancement of innovative GERD devices like minimally invasive surgical options and advanced endoscopic procedures. These technical advances improve patient outcomes by reducing recovery time and enhancing the quality of life.

Growing Awareness and Acceptance

• Awareness and acceptance are improving as patients and medical professionals become more aware of the condition. Thus, increasing awareness about the condition has motivated people suffering from GERD to adopt advanced devices that may help them manage their symptoms.

Restrains:

High Costs

• The acquisition costs of the GERD device are high, though implementation costs are almost the same for every individual. All this means the high cost of treatment creates a big hurdle in market growth, especially in those areas where healthcare resources could be better. Further, continuous maintenance and monitoring of these devices increase the overall cost burden on patients and healthcare facilities. Insurance coverage for GERD devices is also limited, as many require significant out-of-pocket expenses. These can discourage patients from opting for advanced treatment options, even if it is beneficial for them.

Opportunities:

Emerging Markets

• The middle-class population in emerging countries like India, China, and Brazil provides huge scope for the growth of the device market in GERD. Increased disposable income spending due to growing healthcare infrastructure will see a surge in demand for advanced medical treatments, such as GERD devices. This trend is more pronounced in urban areas as the population becomes wealthier and more health-conscious. Moreover, the increase in lifestyle-oriented diseases, including obesity and diabetes, acting as risk factors for GERD, further propels the demand for effective treatment modalities.

The market is segmented based on Device Type, Application, End-User, and Region.

Device Type Insights:

• Anti-Reflux Surgery Devices: These are used in surgical procedures like fundoplication, which involves wrapping the top of the stomach around the lower esophagus to strengthen the valve and avoid reflux. Over the years, this segment has recorded very important developments related to laparoscopic and robotic-assisted surgery. Consequently, this provides less invasive solutions and speedier recoveries for GERD patients.
• Endoscopic Devices: These devices are utilized in the non-surgical treatment of GERD and, to a large extent, are based on endoscopic suturing or radiofrequency therapy for tightening the lower esophageal sphincter. Since endoscopic procedures reduce hospital stay and recovery time, they have emerged as a popular choice among patients and clinicians for the treatment of moderate GERD.
• Drug Delivery Devices Surgery: Drug delivery devices mainly comprise unique systems for the consistent and controlled release of anti-reflux drugs. Several new wearables, such as drug-delivery patches or implantable devices, enhance patient compliance, thus improving drug-based treatments in managing GERD.
• Monitoring Devices: These include pH sensors, manometry devices, and impedance-pH monitoring systems that measure the amount of acid in the esophagus and the effectiveness of treatment. These monitoring devices provide appropriate diagnosis and also assess the success of different interventions in the long-term management of GERD.
• Others: The segment comprises only niche and emerging technologies that do not fall under the major categories. These include experimental devices and hybrid systems that integrate elements of both monitoring and treatment, such as smart sensors embedded in wearables or diagnostic capsules that offer new ways to manage and understand the condition called GERD.

Application Insights:

• Treatment: This segment of application includes devices directly involved in therapeutic intervention for GERD, such as anti-reflux surgery and drug delivery systems. It remains the biggest segment due to the high demand for minimally invasive and highly effective treatment options driven by the prevalence of chronic GERD cases.
• Diagnostics: Diagnostic devices are very useful in investigating the root causes of a problem and, therefore, the seriousness of the disease. pH monitoring systems, manometry, and impedance sensors greatly assess esophageal function and guide treatment decisions to ensure appropriate patient stratification.
• Monitoring: his category includes devices used in the periodic or continual monitoring of patients with GERD regarding how well their disease and treatment are being managed over a long period. Remote monitoring technologies have started to grow because of a growing trend toward telemedicine and managing chronic diseases on an outpatient basis.

End-User Insights:

• Hospitals: Hospitals consume the most GERD devices since they possess modern facilities for surgical, diagnostic, and monitoring procedures. Moreover, complex cases, such as anti-reflux surgeries and high-tech diagnostic assessments, are also performed in hospitals.
• Ambulatory Surgery Centers: These centers have become increasingly popular as treatment options for GERD because of their outpatient orientation. They offer cost-effective and less invasive alternatives for the surgical treatment of GERD, resulting in faster recoveries and less hospital burden.
• Others: This includes specialty clinics, home care settings, and others. Specialty clinics are always considered owing to the frequent monitoring in personalized care for managing GERD conditions, while home care devices are favored by patients who opt for remote diagnosis.

Regional Insights

• North America: North America presently holds the largest GERD devices market share, owing to most cases being contributed by the U.S. and Canada. This could be attributed to a high prevalence rate of GERD along with strong healthcare infrastructure and rising awareness regarding available treatment options. Moreover, technological development and high healthcare expenditure will further enable market growth in this region.
• Asia Pacific: The market is registering a fast growth rate due to increasing awareness about GERD, better access to healthcare, and the growth of lifestyle diseases. In addition to these factors, this region is also showing growth due to the rise in medical tourism and an increase in the number of investors who invest in improving healthcare infrastructure.
• Europe: Europe's share of the GERD device market is immense owing to the growth of its geriatric population and pervasive prevalence of GERD. The region's focus on minimally invasive procedures and innovation in healthcare technologies has enhanced the market growth.
• Latin America: The Latin American market is also developing but at a stable pace, supported by an increase in the number of people with the GERD condition and better infrastructure related to health care; there is also higher awareness of treatment options. Economic differences across countries in the region may limit access to higher-level GERD devices.
• Middle East and Africa: This region's market share is negligible due to economic constraints and a lack of exposure to advanced health technologies. However, with increasing investments in healthcare and growing awareness, the growth is expected to be higher over time.

Gastroesophageal Reflux Disease (GERD) Device Market Report Scope:

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2024 to 2034. For the purpose of this study segmented the target market report based on Device Type, Application, End-User, and Region.

Segmentation:

By Device Type:

• Anti-Reflux Surgery Devices
• Endoscopic Devices
• Drug Delivery Devices Surgery
• Monitoring Devices
• Others

By Application:

• Treatment
• Diagnostics
• Monitoring

By End-User:

• Hospitals
• Ambulatory Surgery Centers
• Others

By Region:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • Israel
  • South Africa
  • Rest of Middle East & Africa

The key players operating the Gastroesophageal Reflux Disease (GERD) Device Market include Medtronic PLC, Johnson & Johnson Services, Inc., Boston Scientific Corporation, EndoStim, Inc., Olympus Corporation, Laborie Medical Technologies, Medigus Ltd., Mederi Therapeutics Inc., Ethicon, Inc. (A subsidiary of Johnson & Johnson), Torax Medical, Inc. (Acquired by Medtronic), Koninklijke Philips N.V., Cook Medical Inc., Diversatek Healthcare Inc., C2 Therapeutics, FUJIFILM Holdings Corporation.

                     To Access More Companies, Download Free Sample PDF

• In August 2024, Medtronic announced the launch of its new Linx Reflux Management System, an advanced anti-reflux surgery device. The system incorporates enhanced magnetic ring technology to improve durability and patient outcomes. This launch reflects Medtronic's commitment to advancing minimally invasive GERD treatments and addressing unmet needs in chronic reflux management.
• In July 2024, Boston Scientific introduced an upgraded version of its Endoscopic Suture System, which enhances the precision and efficiency of endoscopic anti-reflux procedures. The new system features a streamlined delivery mechanism and improved suture materials to reduce procedure times and enhance patient comfort.
• In June 2024, Johnson & Johnson announced a strategic partnership with EndoStim to co-develop next-generation neuromodulation therapies for GERD. This collaboration integrates EndoStim’s neurostimulation technology with Johnson & Johnson’s surgical expertise to offer more effective treatment options for severe GERD cases.

• Medtronic PLC*
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Johnson & Johnson Services, Inc.
• Boston Scientific Corporation
• EndoStim, Inc.
• Olympus Corporation
• Laborie Medical Technologies
• Medigus Ltd.
• Mederi Therapeutics Inc.
• Ethicon, Inc. (A subsidiary of Johnson & Johnson)
• Torax Medical, Inc. (Acquired by Medtronic)
• Koninklijke Philips N.V.
• Cook Medical Inc.
• Diversatek Healthcare Inc.
• C2 Therapeutics
• FUJIFILM Holdings Corporation

“*” marked represents similar segmentation in other categories in the respective section.

Research Objective and Assumption

• Research Objectives
• Assumptions
• Abbreviations

Market Preview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Device Type
  • Market Snippet, By Application
  • Market Snippet, By End-User
  • Market Snippet, By Region
• Opportunity Map Analysis

Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Market Trends
• Product Launch
• Merger and Acquisitions
• Impact Analysis
• PEST Analysis
• Porter’s Analysis

Market Segmentation, By Device Type, Forecast Period up to 10 Years, (USD Bn)

• Overview
  • Market Value and Forecast (USD Bn), and Share Analysis (%), Forecast Period up to 10 Years
  • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
  • Segment Trends
• Anti-Reflux Surgery Devices
  • Overview
  • Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Endoscopic Devices
  • Overview
  • Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Drug Delivery Devices Surgery
  • Overview
  • Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Monitoring Devices
  • Overview
  • Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Others
  • Overview
  • Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

Market Segmentation, By Application, Forecast Period up to 10 Years, (USD Bn)

• Overview
  • Market Value and Forecast (USD Bn), and Share Analysis (%), Forecast Period up to 10 Years
  • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
  • Segment Trends
• Treatment
  • Overview
  • Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Diagnostics
  • Overview
  • Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Monitoring
  • Overview
  • Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

Market Segmentation, By End-User, Forecast Period up to 10 Years, (USD Bn)

• Overview
  • Market Value and Forecast (USD Bn), and Share Analysis (%), Forecast Period up to 10 Years
  • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
  • Segment Trends
• Hospitals
  • Overview
  • Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Ambulatory Surgery Centers
  • Overview
  • Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Others
  • Overview
  • Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

Market Segmentation, By Region, Forecast Period up to 10 Years, (USD Bn)

• Overview
  • Market Value and Forecast (USD Bn), and Share Analysis (%), Forecast Period up to 10 Years
  • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
  • Regional Trends
• North America
  • Market Size and Forecast (USD Bn), By Device Type, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Bn), By Application, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Bn), By End-User, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Bn), By Country, Forecast Period up to 10 Years
    • U.S
    • Canada
• Asia Pacific
  • Market Size and Forecast (USD Bn), By Device Type, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Bn), By Application, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Bn), By End-User, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Bn), By Country, Forecast Period up to 10 Years
    • India
    • Japan
    • South Korea
    • China
    • Rest of Asia Pacific
• Europe
  • Market Size and Forecast (USD Bn), By Device Type, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Bn), By Application, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Bn), By End-User, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Bn), By Country, Forecast Period up to 10 Years
    • UK
    • Germany
    • France
    • Russia
    • Italy
    • Rest of Europe
• Latin America
  • Market Size and Forecast (USD Bn), By Device Type, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Bn), By Application, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Bn), By End-User, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Bn), By Country, Forecast Period up to 10 Years
    • Brazil
    • Mexico
    • Rest of Latin America
• Middle East and Africa
  • Market Size and Forecast (USD Bn), By Device Type, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Bn), By Application, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Bn), By End-User, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Bn), By Country, Forecast Period up to 10 Years
    • GCC
    • Israel
    • South Africa
    • Rest of Middle East and Africa

Competitive Landscape

• Heat Map Analysis
• Company Profiles

• Medtronic PLC
• Johnson & Johnson Services, Inc.
• Boston Scientific Corporation
• EndoStim, Inc.
• Olympus Corporation
• Laborie Medical Technologies
• Medigus Ltd.
• Mederi Therapeutics Inc.
• Ethicon, Inc. (A subsidiary of Johnson & Johnson)
• Torax Medical, Inc. (Acquired by Medtronic)
• Koninklijke Philips N.V.
• Cook Medical Inc.
• Diversatek Healthcare Inc.
• C2 Therapeutics
• FUJIFILM Holdings Corporation

The Last Word

• Future Impact
• About Us
• Contact